The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 931,797 | 3,611,615 | SH | SOLE | 3,611,615 | 0 | 0 | |||
RIGETTI COMPUTING INC | COMMON STOCK | 76655K103 | 104,130 | 88,621 | SH | SOLE | 88,621 | 0 | 0 | |||
UNITY BIOTECHNOLOGY INC | COM NEW | 91381U200 | 125,389 | 49,172 | SH | SOLE | 49,172 | 0 | 0 |